Current status: 977 hESC lines, 6342 hiPSC lines, and 153 clinical studies, and 2335 certificates
Monthly statistic from Aug 1, 2024
Posted on August 1, 2024
| total lines | 7319 |
| hESC lines | 977 |
| hiPSC lines | 6342 |
| derivation countries | 50 |
| projects | 304 |
| providers | 917 |
| clinical studies | 153 |
| subclones | 2956 |
| certificates | 2335 |
| cell line certificates | 2190 |
| project certificates | 145 |